聯絡我們
CONTACT
本平台目的為推廣台灣臨床試驗，提供廠商、研究者及一般民眾臨床試驗之相關訊息。 若您需要刊登受試者招募廣告、臨床試驗相關活動或臨床試驗受托機構訊息，歡迎留下您的資料與聯絡方式，我們會儘速跟您連繫。
若有臨床試驗設計規劃上的諮詢需求，歡迎至財團法人醫藥品查驗中心(CDE)網站的諮詢輔導專區，填寫資料後送出，會有專人與您連繫。
彰化基督教醫療財團法人彰化基督教醫院 臨床試驗中心Changhua Christian Medical Foundation Changhua Christian Hospital Clinical Trial Center
1. 每年執行約150件新藥臨床試驗
2. 彰化基督教醫療體系含括六家分院及1家合作醫院，建立完善的轉介機制
3. 通過國際臨床研究受試者保護評鑑，並榮獲全面通過(Full Accreditation)殊榮
臨床試驗中心簡介
- 於2000年開始執行臨床試驗，並於2007年成立臨床試驗中心，管理及執行臨床試驗計畫，提供優良之臨床試驗品質以及受試者權益之維護。
- 具美國研究人員聯盟(Association of Clinical Research Professionals, ACRP) 認證之CCRC以及台灣護理師臨床研究學會認證之臨床研究護理師
- 臨床研究護理師朝專科化邁進，建立備援機制
- 積極培訓臨床試驗人才，建立教育訓練制度及標準作業流程
- 臨床試驗單ㄧ窗口服務
- 擁有優良之軟硬體設備
- 提供臨床試驗受試者獨立及隱私的空間
臨床試驗重點領域
乳癌、血液腫瘤科、胸腔科、腸胃肝膽科、免疫風濕科、心臟血管科、內分泌科、神經醫學科
國際認證
- Accredited by JCI (Joint Commission International) in 2008, and Reaccredited in 2011 and 2014, 1st Hospital in Taiwan Accredited by 7th JCI (Joint Commission International) in 2017.
- Full Accreditation Awarded by AAHRPP (Association for Accreditation of Human Research Protection Program) in 2015 and Reaccredited in 2018.
GCP查核
TFDA inspection with no major finding
卓越亮點
CTC
-
臨床研究護理師專科化：
-
人體研究專案管理系統：
-
單一窗口服務流程：
近年文獻發表
CTC
1
Lin, C.H., Kuo, S.C., Hsieh, M.C., Ho, S.Y., Su, I.J., Lin, S.H., …., Yeh, Y.P.(2019). Changhua Research Alliance for Tuberculosis Elimination. Effect of diabetes mellitus on risk of latent TB infection in a high TB incidence area: a community-based study in Taiwan. BMJ Open 2019, 9(10):e029948. doi: 10.1136/bmjopen-2019-029948
2
Lai, H.W., Liu, L.C., Ouyang, F., Yao, C.C., Jan, H.C., Chang, Y.H., ….Chen, F.M.(2017). Multi-center study on patient selection for and the oncologic safety of intraoperative radiotherapy (IORT) with the Xoft Axxent® eBx® System for the management of early stage breast cancer in Taiwan. PLoS One. 2017, 2;12(11):e0185876. doi: 10.1371/journal.pone.0185876.
3
Jackisch, C., Hegg, R., Stroyakovskiy, D., Ahn, JS4, Melichar B, Chen, S.C.,…Pivot, X.(2016). HannaH phase III randomised study: Association of total pathological complete response with event-free survival in HER2-positive early breast cancer treated with neoadjuvant-adjuvant trastuzumab after 2 years of treatment-free follow-up. Eur J Cancer, 19(62), 62-75. doi: 10.1016/j.ejca.2016.03.087
4
Lai, T.H., Wang, W.F., Yip, B.S., Yang, Y.W., Peng, G.S., Tsai, S.J., Liao, Y.C.(2016). Pai Real-world evaluation of compliance and preference in Alzheimer's disease treatment: an observational study in Taiwan. Patient Prefer Adherence, 30(10), 383-90. doi: 10.2147/PPA.S95271.
5
Wang, L.W., Hsiao, C.F., Chen, W.T., Lee, H.H., Lin, T.C., Chen, H.C., …Liu, T.W. (2014), Celecoxib Plus Chemoradiotherapy for Locally Advanced Rectal Cancer: A Phase II TCOG study, Journal of Surgical Oncology, 109(6), 580-585. doi: 10.1002/jso.23538
6
Hsu, C., Tsou, H.H., Lin, S.J., Wang, M.C., Yao, M., …Cheng, A.L.(2014), Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: a prospective study, Hepatology, 59(6), 2092-2100. doi: 10.1002/hep.26718
7
Chen, P.H., Tsai, Y.T., Wang, J.S., Lin, S.D., Lee, W.J., Su, S.L., Lee, I.T., …Lin, S.Y.(2014). Post-meal β-cell function predicts the efficacy of glycemic control in patients with type 2 diabetes inadequately controlled by metformin monotherapy after addition of glibenclamide or acarbose. Diabetol Metab Syndr. 6(68). doi: 10.1186/1758-5996-6-68
8
Lai, H.W., Tseng, L.M., Chang, T.W., Kuo, Y.L., Hsieh, C.M., Chen, S.T., Chen, D.R.(2013). The prognostic significance of metaplastic carcinoma of the breast (MCB) - A case controlled comparison study with infiltrating ductal carcinoma. Breast, 22(5), 968-973. doi: 10.1016/j.breast.2013.05.010.
9
Lu, Y.S., Chen, D.R., Tseng, L.M., Yeh, D.C., Chen, S.T., Hsieh, C.M., …Huang, C.S.(2011). Phase II study of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer. Cancer Chemotherapy and Pharmacology, 67(6), 1257-1263. doi: 10.1007/s00280-010-1401-2